Mechanisms of isoniazid resistance in Mycobacterium tuberculosis

Drug Resistance Updates

Volumn 1, Issue 2, 1998, Pages 128-134

  Barry III, Clifton E ^a   Slayden, Richard A ^a   Mdluli, Khisimuzi ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007990632     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80028-9     Document Type: Review

References (50)

1. Bass J.B., Farer L.S., Hopewell P.C., et al. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 149 (1994) 1359-1374
2. WHO/IUATLD. Anti-tuberculosis drug resistance in the world (1997), WHO Global Tuberculosis Programme, Geneva
3. Moore M., Onorato I.M., McCray E., and Castro K.G. Trends in drug-resistant tuberculosis in the United States, 1993-1996. J Am Med Assoc 278 (1997) 833-837
4. Middlebrook G. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am Rev Tuberc 65 (1952) 765-767
5. Mdluli K., and Barry III C.E. Drug sensitivity and environmental adaptation of mycobacterial cell wall components. Trends Microbiol 4 (1996) 275-281
6. Middlebrook G. Isoniazid-resistance and catalase activity of tubercle bacilli. Am Rev Tuberc 69 (1954) 471-472
7. Zhang Y., Heym B., Allen B., Young D., and Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (London) 358 (1992) 591-593
8. Zhang Y., Garbe T., and Young D. Transformation with KatG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol 8 (1993) 521-524
9. Rouse D.A., and Morris S.L. Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infect Immun 63 (1995) 1427-1433
10. Ferrazoli L., Palaci M., Telles M., et al. Catalase expression, katG, and MIC of isoniazid for Mycobacterium tuberculosis isolates from Sao Paulo, Brazil. J Infect Dis 171 (1995) 237-240
11. Heym B., Alzari P.M., Honore N., and Cole S.T. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 15 (1995) 235-245
12. Goto M., Oka S., Tachikawa N., et al. katG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates. Mol Cell Probes 9 (1995) 433-439
13. Stoeckle M.Y., Guan L., Riegler N., et al. Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J Infect Dis 168 (1993) 1063-1065
14. Altamirano M., Marostenmaki J., Fitzgerald A., Black W.A., and Smith J.A. Mutations in the catalase peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. J Infect Dis 169 (1994) 1162-1165
15. Victor T.C., Pretorius G.S., Felix J.V., Jordaan A.M., Helden P., and Eisenach K.D. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent. Antimicrob Agents Chemother 40 (1996) 1572
16. O'Brien K.L., Dietz H.C., Romahnoli M., and Eiden J. Evaluation of inhA gene and catalase-peroxidase gene among isoniazid-sensitive and resistant Mycobacterium tuberculosis isolates. Mol Cell Probes 10 (1996) 1-6
17. Morris S., Bai G.H., Suffys P., Portillo-Gomez L., Fairchok M., and Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 171 (1995) 954-960
18. Heym B., Honore N., Truffot-Pernot C., et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344 (1994) 293-298
19. Musser J.M., Kapur V., Williams D.L., Kreiswirth B.N., Soolingen D., and Embden J. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 173 (1996) 196-202
20. Marttila H.J., Soini H., Huovinen P., and Viljanen M.K. katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother 40 (1996) 2187-2189
21. Rouse D.A., DeVito J.A., Li Z., Byer H., and Morris S.L. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol 22 (1996) 583-592
22. Wengenack N.L., Uhl J.R., Amand A., et al. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis 176 (1997) 722-727
23. Johnsson K., Froland W.A., and Schultz P.G. Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J Biol Chem 272 (1997) 2834-2840
24. Lee A.-G., Tang L.-H., Lim I.-K., Ling M.-L., Tay L., and Wong S.-Y. Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore. J Infect Dis 176 (1997) 1125-1126
25. Telenti A., Honore N., Bernasconi C., et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35 (1997) 719-723
26. Sherman D.R., Sabo P.J., Hickey M.J., et al. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc Natl Acad Sci USA 92 (1995) 6625-6629
27. Deretic V., Philipp W., Dhandayuthapani S., et al. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol Microbiol 17 (1995) 889-900
28. Wilson T.M., Lisle G., and Collins D.M. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol 15 (1995) 1009-1015
29. Sherman D.R., Mdluli K., Hickey M.J., et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272 (1996) 1641-1643
30. Wilson T.M., and Collins D.M. aphC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol Microbiol 19 (1996) 1025-1034
31. Zhang Y., Dhandayuthapani S., and Deretic V. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc Natl Acad Sci USA 93 (1996) 13212-13216
32. Sreevatsan S., Pan X., Zhang Y., Deretic V., and Musser J.M. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother 41 (1997) 600-606
33. Kelley C.L., Rouse D.A., and Morris S.L. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 41 (1997) 2057-2058
34. Heym B., Stavropoulos E., Honore N., et al. Effects of overexpression of the alkylhydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect Immun 65 (1997) 1395-1401
35. Winder F.G. Mode of action of antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria. In: Ratledge C., and Standford J. (Eds). The Biology of the Mycobacteria (1982), Academic Press, London 353-438
36. Takayama K., Wang L., and David H.L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2 (1972) 29-35
37. Takayama K., Wang L., and Merkal R.S. Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid. Antimicrob Agents Chemother 4 (1973) 62-65
38. Takayama K., Keith A.D., and Snipes W. Effect of isoniazid on the protoplasmic viscosity in Mycobacterium tuberculosis. Antimicrob Agents Chemother 7 (1975) 22-24
39. Takayama K., Schnoes H.K., Armstrong E.L., and Boyle R.W. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J Lipid Res 16 (1975) 308-317
40. Davidson L.A., and Takayama K. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 16 (1979) 104-105
41. Banerjee A., Dubnau E., Quemard A., et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263 (1994) 227-230
42. Mdluli K., Sherman D.R., Hickey M.J., et al. Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infect Dis 174 (1996) 1085-1090
43. Dessen A., Quenmard A., Blanchard Jr. J.S., WRJ, and Sacchettini J.C. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267 (1995) 1638-1641
44. Quemard A., Sacchettini J.C., Dessen A., et al. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34 (1995) 8235-8241
45. Ristow M., Monlig M., Rifal M., Schatz H., Feldmann K., and Pfeliffer A. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 346 (1995) 502-503
46. Rouse D.A., Li Z., Bai G.-H., and Morris S.L. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 39 (1995) 2472-2477
47. Kapur V., Li L.-L., Hamrick M.R., et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med 119 (1995) 131-138
48. Shoeb H.A., Bernard U., Bowman J., Ottolenghi A.C., and Merola A.J. Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 27 (1985) 404-407
49. Shoeb H.A., Bernard U., Bowman J., Ottolenghi A.C., and Merola A.J. Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid. Antimicrob Agents Chemother 27 (1985) 408-412
50. (in press). Mdluli K., Swanson J., Fischer E., Lee R.E., and Barry III C.E. Mechanisms involved in the intrinsic isoniazid-resistance of Mycobacterium avium. Mol Microbiol (1998)